Decitabine Followed by Donor Lymphocyte Infusion for Patients With Relapsed Acute Myeloblastic Leukemia(AML) After Allogeneic Stem Cell Transplantation

NCT01758367 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

UNKNOWN

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Recurrent Adult Acute Myeloid Leukemia

Interventions

DRUG: Deciatbine(DAC)

Sponsor

Chinese PLA General Hospital

Collaborators

[object Object]